OMEPRAZOLE

OMEPRAZOLE was reported 441658 times

These side effects are most commonly reported by patients taking OMEPRAZOLE:

# Side effect Count
0 FATIGUE 20984
1 NAUSEA 20910
2 DIARRHOEA 20740
3 DYSPNOEA 17208
4 DRUG INEFFECTIVE 16608
5 HEADACHE 15565
6 PAIN 14472
7 VOMITING 13956
8 DIZZINESS 13897
9 CHRONIC KIDNEY DISEASE 13585
10 OFF LABEL USE 13568
11 ACUTE KIDNEY INJURY 12045
12 MALAISE 11384
13 ARTHRALGIA 11259
14 ASTHENIA 11142
15 FALL 11112
16 PNEUMONIA 10308
17 DEATH 9882
18 PYREXIA 9368
19 COUGH 8848
20 RASH 8734
21 PRURITUS 8496
22 WEIGHT DECREASED 8482
23 PAIN IN EXTREMITY 8456
24 DRUG INTERACTION 8135
25 ABDOMINAL PAIN 7794
26 CONSTIPATION 7726
27 BACK PAIN 7344
28 RENAL FAILURE 7325
29 DECREASED APPETITE 7248
30 ANXIETY 7215
31 ABDOMINAL PAIN UPPER 7036
32 INSOMNIA 6943
33 ANAEMIA 6644
34 CONDITION AGGRAVATED 6641
35 HYPOTENSION 6333
36 URINARY TRACT INFECTION 6297
37 DEPRESSION 6095
38 CHEST PAIN 6082
39 CONFUSIONAL STATE 5971
40 HYPERTENSION 5776
41 FEELING ABNORMAL 5520
42 GASTROOESOPHAGEAL REFLUX DISEASE 5386
43 GAIT DISTURBANCE 5208
44 MUSCLE SPASMS 5181
45 PERIPHERAL SWELLING 5146
46 PRODUCT DOSE OMISSION ISSUE 5112
47 SOMNOLENCE 5005
48 ABDOMINAL DISCOMFORT 4972
49 DEHYDRATION 4933
50 MYALGIA 4780
51 WEIGHT INCREASED 4643
52 TREMOR 4461
53 COVID-19 4374
54 ALOPECIA 4310
55 PARAESTHESIA 4254
56 BLOOD PRESSURE INCREASED 3945
57 NASOPHARYNGITIS 3912
58 MUSCULAR WEAKNESS 3881
59 MEMORY IMPAIRMENT 3865
60 INJECTION SITE PAIN 3841
61 PRODUCT USE IN UNAPPROVED INDICATION 3832
62 DYSPEPSIA 3824
63 OEDEMA PERIPHERAL 3821
64 HYPONATRAEMIA 3763
65 HYPERHIDROSIS 3746
66 END STAGE RENAL DISEASE 3707
67 HYPOAESTHESIA 3692
68 ERYTHEMA 3616
69 SEPSIS 3609
70 HAEMOGLOBIN DECREASED 3509
71 ATRIAL FIBRILLATION 3469
72 BALANCE DISORDER 3447
73 PALPITATIONS 3441
74 VISION BLURRED 3341
75 CEREBROVASCULAR ACCIDENT 3219
76 INFECTION 3191
77 RENAL IMPAIRMENT 3190
78 SYNCOPE 3170
79 MYOCARDIAL INFARCTION 3145
80 HYPERSENSITIVITY 3130
81 CONTUSION 3113
82 JOINT SWELLING 3099
83 THROMBOCYTOPENIA 3095
84 ABDOMINAL DISTENSION 3094
85 LOSS OF CONSCIOUSNESS 3090
86 INFLUENZA 3051
87 NEUTROPENIA 3044
88 SINUSITIS 3026
89 BLOOD GLUCOSE INCREASED 3008
90 GASTROINTESTINAL HAEMORRHAGE 3005
91 TOXICITY TO VARIOUS AGENTS 2994
92 PLATELET COUNT DECREASED 2910
93 HEART RATE INCREASED 2908
94 DYSPHAGIA 2886
95 URTICARIA 2877
96 CHEST DISCOMFORT 2870
97 RENAL INJURY 2867
98 ASTHMA 2814
99 VISUAL IMPAIRMENT 2800
100 PULMONARY EMBOLISM 2799
101 PRODUCT USE ISSUE 2792
102 CHILLS 2788
103 DRUG DOSE OMISSION 2788
104 OROPHARYNGEAL PAIN 2782
105 DRY MOUTH 2737
106 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2730
107 DRUG HYPERSENSITIVITY 2718
108 NEUROPATHY PERIPHERAL 2717
109 TACHYCARDIA 2704
110 HALLUCINATION 2650
111 HYPOMAGNESAEMIA 2620
112 WHITE BLOOD CELL COUNT DECREASED 2616
113 HYPOKALAEMIA 2550
114 INCORRECT DOSE ADMINISTERED 2547
115 MIGRAINE 2547
116 SEIZURE 2530
117 TUBULOINTERSTITIAL NEPHRITIS 2501
118 ARTHRITIS 2486
119 DRY SKIN 2462
120 GENERAL PHYSICAL HEALTH DETERIORATION 2422
121 BRONCHITIS 2391
122 ILLNESS 2360
123 EPISTAXIS 2331
124 FLUSHING 2275
125 MOBILITY DECREASED 2262
126 BLOOD CREATININE INCREASED 2222
127 RHEUMATOID ARTHRITIS 2220
128 PSORIASIS 2215
129 SWELLING 2199
130 DISEASE PROGRESSION 2189
131 GASTROINTESTINAL DISORDER 2171
132 RESPIRATORY FAILURE 2156
133 HOSPITALISATION 2126
134 CARDIAC FAILURE 2089
135 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2080
136 RENAL FAILURE ACUTE 2043
137 COGNITIVE DISORDER 2030
138 INTENTIONAL PRODUCT USE ISSUE 2028
139 CARDIAC FAILURE CONGESTIVE 2012
140 FLATULENCE 2008
141 MUSCULOSKELETAL STIFFNESS 2007
142 OVERDOSE 2001
143 DYSGEUSIA 1994
144 LETHARGY 1984
145 THROMBOSIS 1957
146 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1948
147 INTENTIONAL PRODUCT MISUSE 1941
148 FEBRILE NEUTROPENIA 1934
149 AMNESIA 1922
150 DEEP VEIN THROMBOSIS 1905
151 HOT FLUSH 1902
152 OXYGEN SATURATION DECREASED 1862
153 SLEEP DISORDER 1853
154 DIABETES MELLITUS 1844
155 TINNITUS 1832
156 LOWER RESPIRATORY TRACT INFECTION 1825
157 AGITATION 1822
158 PRODUCTIVE COUGH 1815
159 PLEURAL EFFUSION 1813
160 WHEEZING 1802
161 PANCYTOPENIA 1798
162 SWELLING FACE 1797
163 ALANINE AMINOTRANSFERASE INCREASED 1793
164 HAEMORRHAGE 1791
165 HYPOCALCAEMIA 1777
166 VERTIGO 1767
167 CARDIAC ARREST 1763
168 RECTAL HAEMORRHAGE 1761
169 NECK PAIN 1757
170 DYSPHONIA 1743
171 SUICIDAL IDEATION 1733
172 RHINORRHOEA 1731
173 STRESS 1713
174 BLOOD PRESSURE DECREASED 1693
175 DISTURBANCE IN ATTENTION 1691
176 CATARACT 1690
177 BURNING SENSATION 1683
178 BONE PAIN 1680
179 CARDIAC DISORDER 1670
180 OSTEOARTHRITIS 1660
181 SKIN EXFOLIATION 1626
182 CELLULITIS 1617
183 EYE PAIN 1613
184 INFLUENZA LIKE ILLNESS 1604
185 PRODUCT QUALITY ISSUE 1600
186 STOMATITIS 1567
187 EMOTIONAL DISTRESS 1559
188 NEPHROLITHIASIS 1556
189 BLISTER 1546
190 GASTRITIS 1536
191 INJECTION SITE ERYTHEMA 1525
192 HYPOGLYCAEMIA 1524
193 ARTHROPATHY 1515
194 OSTEOPOROSIS 1500
195 BRADYCARDIA 1497
196 DYSPNOEA EXERTIONAL 1493
197 RHABDOMYOLYSIS 1480
198 MALIGNANT NEOPLASM PROGRESSION 1479
199 FEELING HOT 1476
200 ANGIOEDEMA 1473
201 FLUID RETENTION 1473
202 OEDEMA 1466
203 HYPERKALAEMIA 1465
204 LIP SWELLING 1460
205 HAEMATOCHEZIA 1459
206 MUSCULOSKELETAL PAIN 1448
207 NASAL CONGESTION 1448
208 DYSURIA 1402
209 ADVERSE DRUG REACTION 1400
210 DRUG INTOLERANCE 1398
211 RENAL DISORDER 1385
212 MEDICATION ERROR 1380
213 UPPER RESPIRATORY TRACT INFECTION 1374
214 TRANSIENT ISCHAEMIC ATTACK 1368
215 SEPTIC SHOCK 1367
216 ASPARTATE AMINOTRANSFERASE INCREASED 1365
217 INFLAMMATION 1362
218 RASH PRURITIC 1361
219 DEPRESSED MOOD 1354
220 PANCREATITIS 1353
221 POLLAKIURIA 1350
222 PULMONARY OEDEMA 1343
223 CROHN^S DISEASE 1341
224 SPEECH DISORDER 1341
225 THROAT IRRITATION 1337
226 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1336
227 HERPES ZOSTER 1333
228 HAEMATURIA 1324
229 ORTHOSTATIC HYPOTENSION 1323
230 SWOLLEN TONGUE 1301
231 DEPRESSED LEVEL OF CONSCIOUSNESS 1296
232 BLOOD CHOLESTEROL INCREASED 1293
233 PRODUCT DOSE OMISSION 1288
234 DISORIENTATION 1275
235 HEPATIC ENZYME INCREASED 1265
236 WHITE BLOOD CELL COUNT INCREASED 1265
237 LUNG DISORDER 1259
238 UNEVALUABLE EVENT 1244
239 ARRHYTHMIA 1242
240 THERAPY INTERRUPTED 1239
241 INTERNATIONAL NORMALISED RATIO INCREASED 1236
242 LIVER FUNCTION TEST ABNORMAL 1230
243 BLOOD POTASSIUM DECREASED 1223
244 ELECTROCARDIOGRAM QT PROLONGED 1214
245 SKIN DISCOLOURATION 1214
246 NERVOUSNESS 1208
247 CHOLELITHIASIS 1204
248 DRY EYE 1188
249 SURGERY 1175
250 DISCOMFORT 1160
251 HYPOXIA 1158
252 ANAPHYLACTIC REACTION 1156
253 URINARY RETENTION 1154
254 LEUKOPENIA 1152
255 INFUSION RELATED REACTION 1139
256 C-REACTIVE PROTEIN INCREASED 1129
257 NO ADVERSE EVENT 1106
258 DELIRIUM 1103
259 COLITIS 1102
260 DYSARTHRIA 1095
261 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1089
262 EYE IRRITATION 1086
263 HAEMATEMESIS 1077
264 COMPLETED SUICIDE 1076
265 URINARY INCONTINENCE 1072
266 RASH ERYTHEMATOUS 1071
267 INTESTINAL OBSTRUCTION 1065
268 PRODUCT SUBSTITUTION ISSUE 1057
269 SEDATION 1051
270 INJECTION SITE BRUISING 1049
271 CARDIO-RESPIRATORY ARREST 1040
272 THERAPY CESSATION 1040
273 NIGHTMARE 1035
274 RESPIRATORY TRACT INFECTION 1027
275 DYSKINESIA 1021
276 IRRITABILITY 1021
277 ADVERSE EVENT 1017
278 HAEMOPTYSIS 1011
279 BLINDNESS 1007
280 CYSTITIS 1005
281 DIPLOPIA 997
282 TREATMENT NONCOMPLIANCE 996
283 ECZEMA 995
284 DIVERTICULITIS 991
285 INJECTION SITE PRURITUS 989
286 MUSCLE TWITCHING 984
287 NIGHT SWEATS 979
288 DEVICE ISSUE 967
289 ACUTE MYOCARDIAL INFARCTION 965
290 BLOOD CALCIUM DECREASED 962
291 METABOLIC ACIDOSIS 960
292 LIVER DISORDER 959
293 INTERSTITIAL LUNG DISEASE 951
294 INJURY 950
295 ASCITES 949
296 NEUTROPHIL COUNT DECREASED 947
297 BLOOD ALKALINE PHOSPHATASE INCREASED 944
298 HIATUS HERNIA 944
299 HYPERGLYCAEMIA 937
300 EYE PRURITUS 936
301 RED BLOOD CELL COUNT DECREASED 936
302 INJECTION SITE SWELLING 933
303 PANCREATITIS ACUTE 932
304 HEAD INJURY 924
305 STAPHYLOCOCCAL INFECTION 920
306 HYPOPHAGIA 915
307 MULTIPLE SCLEROSIS RELAPSE 914
308 MELAENA 910
309 PLASMA CELL MYELOMA 907
310 CHROMATURIA 906
311 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 905
312 CONVULSION 901
313 GASTRIC DISORDER 901
314 ANGINA PECTORIS 898
315 RASH MACULAR 892
316 LYMPHADENOPATHY 891
317 INJECTION SITE HAEMORRHAGE 887
318 RESTLESSNESS 886
319 APHASIA 882
320 DISEASE RECURRENCE 879
321 UPPER GASTROINTESTINAL HAEMORRHAGE 879
322 LIMB DISCOMFORT 874
323 NEPHROGENIC ANAEMIA 867
324 SLEEP APNOEA SYNDROME 863
325 HYPOTHYROIDISM 862
326 PNEUMONITIS 862
327 HIP FRACTURE 855
328 BLOOD SODIUM DECREASED 854
329 HEART RATE DECREASED 851
330 JAUNDICE 851
331 ORAL PAIN 848
332 CEREBRAL HAEMORRHAGE 841
333 IMPAIRED GASTRIC EMPTYING 840
334 UNDERDOSE 838
335 FAECES DISCOLOURED 837
336 HAEMATOMA 836
337 CLOSTRIDIUM DIFFICILE INFECTION 830
338 NEURALGIA 826
339 GAIT INABILITY 824
340 MUCOSAL INFLAMMATION 824
341 FEELING COLD 821
342 MATERNAL EXPOSURE DURING PREGNANCY 821
343 HYPOACUSIS 818
344 VIRAL INFECTION 818
345 VENTRICULAR TACHYCARDIA 816
346 ACUTE RESPIRATORY FAILURE 810
347 LIMB INJURY 810
348 NEOPLASM MALIGNANT 810
349 NEPHROPATHY 810
350 BLOOD BILIRUBIN INCREASED 805
351 CORONARY ARTERY DISEASE 803
352 FUNGAL INFECTION 802
353 OCULAR HYPERAEMIA 800
354 INTENTIONAL OVERDOSE 799
355 HYPERSOMNIA 796
356 PAIN IN JAW 794
357 PRESYNCOPE 793
358 SKIN ULCER 793
359 DYSSTASIA 787
360 HEPATIC FAILURE 787
361 INTERVERTEBRAL DISC PROTRUSION 787
362 FIBROMYALGIA 786
363 RESTLESS LEGS SYNDROME 785
364 AGGRESSION 783
365 ILL-DEFINED DISORDER 782
366 BLOOD CREATINE PHOSPHOKINASE INCREASED 781
367 FOETAL EXPOSURE DURING PREGNANCY 780
368 GAMMA-GLUTAMYLTRANSFERASE INCREASED 780
369 MOUTH ULCERATION 776
370 THERAPEUTIC RESPONSE UNEXPECTED 776
371 COLITIS ULCERATIVE 775
372 PSORIATIC ARTHROPATHY 773
373 PALLOR 772
374 PANIC ATTACK 772
375 THERAPEUTIC RESPONSE DECREASED 771
376 MENTAL DISORDER 770
377 TOXIC EPIDERMAL NECROLYSIS 769
378 MOVEMENT DISORDER 767
379 HAEMATOCRIT DECREASED 763
380 IMPAIRED HEALING 763
381 FEMUR FRACTURE 762
382 TYPE 2 DIABETES MELLITUS 761
383 INJECTION SITE REACTION 757
384 EYE SWELLING 750
385 RASH PAPULAR 750
386 ROAD TRAFFIC ACCIDENT 747
387 COMA 745
388 DRUG EFFECT DECREASED 743
389 LOCALISED INFECTION 743
390 MENTAL STATUS CHANGES 743
391 HEPATIC STEATOSIS 741
392 PROTEINURIA 741
393 RIB FRACTURE 733
394 PULMONARY HYPERTENSION 729
395 BLOOD UREA INCREASED 726
396 SUICIDE ATTEMPT 726
397 ANHEDONIA 724
398 SEASONAL ALLERGY 722
399 AGEUSIA 719
400 FREQUENT BOWEL MOVEMENTS 719
401 BLOOD GLUCOSE DECREASED 714
402 DEMENTIA 713
403 DRUG ABUSE 713
404 HEPATITIS 713
405 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 708
406 RESPIRATORY DISTRESS 705
407 PNEUMONIA ASPIRATION 703
408 ABNORMAL BEHAVIOUR 699
409 GASTRIC ULCER 698
410 PAIN OF SKIN 698
411 THERAPY NON-RESPONDER 698
412 RESPIRATORY DISORDER 697
413 HAEMORRHOIDS 692
414 SEROTONIN SYNDROME 692
415 HALLUCINATION, VISUAL 689
416 LACTIC ACIDOSIS 687
417 UNRESPONSIVE TO STIMULI 685
418 LACRIMATION INCREASED 684
419 DEVICE MALFUNCTION 683
420 SINUS DISORDER 682
421 OESOPHAGITIS 681
422 KIDNEY INFECTION 678
423 EXPOSURE DURING PREGNANCY 676
424 RETCHING 676
425 EAR INFECTION 674
426 WITHDRAWAL SYNDROME 674
427 IMPAIRED QUALITY OF LIFE 672
428 SYSTEMIC LUPUS ERYTHEMATOSUS 671
429 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 670
430 DRUG-INDUCED LIVER INJURY 668
431 OSTEOPENIA 668
432 HEPATIC FUNCTION ABNORMAL 657
433 THROAT TIGHTNESS 656
434 SKIN LESION 655
435 ACCIDENTAL OVERDOSE 652
436 DRUG WITHDRAWAL SYNDROME 651
437 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 648
438 JOINT STIFFNESS 648
439 VASCULITIS 648
440 ENCEPHALOPATHY 646
441 BLOOD PRESSURE FLUCTUATION 644
442 SKIN DISORDER 642
443 DIALYSIS 640
444 EATING DISORDER 639
445 SUBARACHNOID HAEMORRHAGE 637
446 LEUKOCYTOSIS 635
447 CIRCULATORY COLLAPSE 633
448 CRYING 633
449 HEART RATE IRREGULAR 628
450 FULL BLOOD COUNT DECREASED 627
451 LABORATORY TEST ABNORMAL 627
452 FEEDING DISORDER 625
453 CHOLESTASIS 624
454 CREATININE RENAL CLEARANCE DECREASED 624
455 MUSCULOSKELETAL CHEST PAIN 624
456 INTENTIONAL DOSE OMISSION 619
457 FACIAL PAIN 617
458 PRODUCT DOSE OMISSION IN ERROR 616
459 SPINAL FRACTURE 615
460 DRUG DEPENDENCE 613
461 PERICARDIAL EFFUSION 613
462 BREAST CANCER 608
463 EYE DISORDER 605
464 PSYCHOTIC DISORDER 605
465 MULTIPLE ORGAN DYSFUNCTION SYNDROME 604
466 TASTE DISORDER 603
467 ERUCTATION 602
468 BLOOD PRESSURE ABNORMAL 599
469 PERICARDITIS 598
470 BLOOD MAGNESIUM DECREASED 593
471 CHOKING 592
472 DRUG LEVEL INCREASED 592
473 TOOTH DISORDER 592
474 POOR QUALITY SLEEP 589
475 DEAFNESS 588
476 PULMONARY FIBROSIS 588
477 RASH MACULO-PAPULAR 587
478 REBOUND ACID HYPERSECRETION 587
479 KNEE ARTHROPLASTY 586
480 FOOT FRACTURE 583
481 EAR PAIN 582
482 GOUT 582
483 IRRITABLE BOWEL SYNDROME 581
484 ANOSMIA 580
485 RENAL CYST 580
486 CANDIDA INFECTION 579
487 NOCTURIA 579
488 SNEEZING 579
489 GALLBLADDER DISORDER 576
490 IRON DEFICIENCY ANAEMIA 576
491 THERAPEUTIC PRODUCT EFFECT DECREASED 576
492 JOINT INJURY 573
493 WOUND 573
494 MOOD SWINGS 570
495 SKIN BURNING SENSATION 569
496 HEPATIC CIRRHOSIS 568
497 HERNIA 567
498 SEDATION COMPLICATION 565
499 HEPATOTOXICITY 562
500 ACCIDENTAL EXPOSURE TO PRODUCT 560
501 DERMATITIS ATOPIC 560
502 MENTAL IMPAIRMENT 558
503 ABNORMAL DREAMS 557
504 BONE DISORDER 557
505 ELECTROLYTE IMBALANCE 557
506 VISUAL ACUITY REDUCED 557
507 ABASIA 556
508 MULTIPLE SCLEROSIS 555
509 STEVENS-JOHNSON SYNDROME 555
510 ACNE 554
511 EMOTIONAL DISORDER 548
512 MUSCULOSKELETAL DISCOMFORT 548
513 LUNG NEOPLASM MALIGNANT 547
514 ORAL CANDIDIASIS 546
515 RASH GENERALISED 546
516 PRURITUS GENERALISED 545
517 TREATMENT FAILURE 545
518 NEOPLASM PROGRESSION 544
519 GASTROENTERITIS VIRAL 542
520 NEUTROPENIC SEPSIS 542
521 HEAD DISCOMFORT 541
522 BLOOD POTASSIUM INCREASED 540
523 GASTROENTERITIS 540
524 CONTRAINDICATED PRODUCT ADMINISTERED 538
525 BLOOD URINE PRESENT 535
526 WRONG TECHNIQUE IN DRUG USAGE PROCESS 534
527 EOSINOPHILIA 533
528 ULCER 529
529 UPPER LIMB FRACTURE 528
530 ANGER 527
531 OBESITY 527
532 SCIATICA 526
533 COAGULOPATHY 525
534 GLOSSODYNIA 524
535 BODY TEMPERATURE INCREASED 523
536 DRUG EFFECT INCOMPLETE 523
537 PHOTOPHOBIA 520
538 CLOSTRIDIUM DIFFICILE COLITIS 516
539 PROCEDURAL PAIN 515
540 ERECTILE DYSFUNCTION 512
541 EPILEPSY 511
542 VITAMIN D DEFICIENCY 510
543 ECONOMIC PROBLEM 505
544 BONE DENSITY DECREASED 503
545 PLATELET COUNT INCREASED 503
546 ABDOMINAL PAIN LOWER 502
547 CARPAL TUNNEL SYNDROME 501
548 IMMUNODEFICIENCY 501
549 TENSION HEADACHE 501
550 LYMPHOCYTE COUNT DECREASED 500
551 HEMIPARESIS 498
552 TRANSAMINASES INCREASED 498
553 BLOOD PRESSURE SYSTOLIC INCREASED 494
554 MULTI-ORGAN FAILURE 494
555 PARKINSON^S DISEASE 489
556 HYPERLIPIDAEMIA 488
557 INFUSION SITE PAIN 486
558 CAROTID ARTERY OCCLUSION 485
559 INJECTION SITE MASS 485
560 LUNG INFECTION 485
561 POST PROCEDURAL COMPLICATION 484
562 PULMONARY MASS 483
563 BACTERIAL INFECTION 482
564 ISCHAEMIC STROKE 482
565 ROTATOR CUFF SYNDROME 482
566 CHOLECYSTITIS 479
567 PNEUMOTHORAX 479
568 LOCAL SWELLING 478
569 MIDDLE INSOMNIA 475
570 NEUTROPHIL COUNT INCREASED 475
571 BACK DISORDER 473
572 FEAR 471
573 SPINAL OSTEOARTHRITIS 471
574 SMALL INTESTINAL OBSTRUCTION 470
575 THYROID DISORDER 470
576 CYTOKINE RELEASE SYNDROME 467
577 RHINITIS 465
578 SPLENOMEGALY 465
579 THIRST 465
580 HYPOAESTHESIA ORAL 464
581 MOOD ALTERED 464
582 ATRIAL TACHYCARDIA 463
583 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 463
584 BLOOD TRIGLYCERIDES INCREASED 462
585 PRODUCT STORAGE ERROR 459
586 AGRANULOCYTOSIS 457
587 TENDONITIS 456
588 TOOTHACHE 453
589 CYANOSIS 452
590 CORONARY ARTERY OCCLUSION 451
591 ACTIVITIES OF DAILY LIVING IMPAIRED 450
592 CARDIOMEGALY 448
593 GLOMERULAR FILTRATION RATE DECREASED 448
594 PHOTOSENSITIVITY REACTION 448
595 BLOOD IRON DECREASED 447
596 COVID-19 PNEUMONIA 447
597 GLAUCOMA 447
598 RESPIRATORY TRACT CONGESTION 447
599 BLOOD COUNT ABNORMAL 446
600 BODY HEIGHT DECREASED 444
601 IMPAIRED WORK ABILITY 444
602 PARAESTHESIA ORAL 444
603 HEPATIC ENCEPHALOPATHY 443
604 LIVER INJURY 443
605 LIVER FUNCTION TEST INCREASED 440
606 ANKLE FRACTURE 437
607 INTERVERTEBRAL DISC DEGENERATION 435
608 DIABETES MELLITUS INADEQUATE CONTROL 434
609 INCORRECT PRODUCT ADMINISTRATION DURATION 434
610 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 434
611 COORDINATION ABNORMAL 432
612 OSTEONECROSIS OF JAW 432
613 PROSTATE CANCER 432
614 APHONIA 431
615 SINUS CONGESTION 431
616 HAIR COLOUR CHANGES 430
617 PERIPHERAL COLDNESS 430
618 ORAL HERPES 429
619 ABNORMAL LOSS OF WEIGHT 428
620 MALNUTRITION 428
621 PRURITUS GENITAL 427
622 COLD SWEAT 426
623 RENAL TUBULAR NECROSIS 426
624 BASAL CELL CARCINOMA 425
625 ORAL DISCOMFORT 425
626 HYPOPHOSPHATAEMIA 422
627 HAIR TEXTURE ABNORMAL 421
628 OSTEOMYELITIS 420
629 DIABETIC KETOACIDOSIS 418
630 LOWER LIMB FRACTURE 417
631 PARANOIA 417
632 GINGIVAL PAIN 416
633 RENAL PAIN 416
634 SKIN FISSURES 416
635 SPINAL PAIN 416
636 ACUTE RESPIRATORY DISTRESS SYNDROME 413
637 DERMATITIS 413
638 FEELING JITTERY 413
639 SLEEP TERROR 413
640 INJECTION SITE RASH 412
641 PRODUCT PRESCRIBING ERROR 412
642 INSURANCE ISSUE 411
643 SUBDURAL HAEMATOMA 411
644 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 408
645 MUSCLE RIGIDITY 407
646 SENSORY DISTURBANCE 403
647 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 402
648 MUSCULOSKELETAL DISORDER 402
649 CONJUNCTIVITIS 401
650 POLYURIA 401
651 SKIN CANCER 401
652 PULMONARY CONGESTION 400
653 BRONCHIECTASIS 399
654 BURSITIS 399
655 INCONTINENCE 399
656 BRAIN FOG 398
657 CARDIOSPASM 396
658 EJECTION FRACTION DECREASED 396
659 VAGINAL HAEMORRHAGE 396
660 PHARYNGITIS 395
661 DEVICE RELATED INFECTION 394
662 MICTURITION URGENCY 394
663 PERITONITIS 394
664 FLUID OVERLOAD 391
665 GASTROINTESTINAL PAIN 391
666 GLYCOSYLATED HAEMOGLOBIN INCREASED 391
667 PALMOPLANTAR KERATODERMA 391
668 THERAPEUTIC RESPONSE SHORTENED 391
669 ALTERED STATE OF CONSCIOUSNESS 390
670 NERVOUS SYSTEM DISORDER 390
671 ANAPHYLACTIC SHOCK 388
672 MANIA 388
673 ATELECTASIS 387
674 FOOT DEFORMITY 387
675 MITRAL VALVE INCOMPETENCE 387
676 PHARYNGEAL OEDEMA 387
677 ASPIRATION 386
678 MYOCLONUS 386
679 EXPIRED PRODUCT ADMINISTERED 385
680 DIZZINESS POSTURAL 384
681 THINKING ABNORMAL 384
682 DELUSION 381
683 DIABETIC NEPHROPATHY 380
684 BLOOD LACTATE DEHYDROGENASE INCREASED 379
685 PAROSMIA 379
686 BRONCHOSPASM 378
687 SUPRAVENTRICULAR TACHYCARDIA 378
688 RESPIRATORY ARREST 376
689 INCORRECT DRUG ADMINISTRATION DURATION 375
690 TENDON RUPTURE 375
691 TOOTH INFECTION 375
692 BONE MARROW FAILURE 374
693 OSTEONECROSIS 374
694 WRIST FRACTURE 374
695 MASS 373
696 SENSORY LOSS 372
697 SKIN HAEMORRHAGE 372
698 PRODUCT ADMINISTRATION INTERRUPTED 369
699 BLADDER DISORDER 367
700 HAEMORRHAGE INTRACRANIAL 367
701 SHOCK 367
702 DRUG ADMINISTRATION ERROR 366
703 CARDIAC MURMUR 364
704 GINGIVAL BLEEDING 363
705 PRODUCT AVAILABILITY ISSUE 361
706 SINUS TACHYCARDIA 360
707 FACE OEDEMA 359
708 HOSPICE CARE 359
709 UROSEPSIS 359
710 CEREBRAL INFARCTION 358
711 NODULE 357
712 MYOCARDIAL ISCHAEMIA 355
713 SCAR 353
714 EXTRA DOSE ADMINISTERED 352
715 GENERALISED OEDEMA 352
716 INCREASED APPETITE 352
717 HEPATOMEGALY 350
718 INTENTIONAL SELF-INJURY 350
719 PARKINSONISM 348
720 SPUTUM DISCOLOURED 348
721 APATHY 346
722 CARDIOVASCULAR DISORDER 346
723 HYPOKINESIA 346
724 EMPHYSEMA 345
725 HYPERCHLORHYDRIA 345
726 INCREASED TENDENCY TO BRUISE 344
727 METASTASES TO LIVER 344
728 PULMONARY THROMBOSIS 343
729 GENERALISED TONIC-CLONIC SEIZURE 341
730 URINE OUTPUT DECREASED 340
731 HYPERPARATHYROIDISM SECONDARY 339
732 MUSCLE TIGHTNESS 339
733 PRODUCT ADMINISTRATION ERROR 339
734 SKIN IRRITATION 339
735 VITAMIN D DECREASED 339
736 FRACTURE 338
737 HALLUCINATION, AUDITORY 338
738 PREMATURE BABY 338
739 DERMATITIS CONTACT 337
740 HIP ARTHROPLASTY 337
741 ATAXIA 336
742 NERVE COMPRESSION 336
743 SKIN LACERATION 336
744 TENDERNESS 336
745 ATRIAL FLUTTER 335
746 CYST 335
747 HAIR DISORDER 335
748 SKIN INFECTION 335
749 PETECHIAE 334
750 HYPERTENSIVE NEPHROPATHY 333
751 CHOLECYSTECTOMY 332
752 DENTAL CARIES 332
753 DEVICE DISLOCATION 332
754 PRESCRIBED UNDERDOSE 332
755 TOOTH LOSS 332
756 EYE INFECTION 331
757 METASTASES TO BONE 331
758 BEDRIDDEN 330
759 PRE-EXISTING CONDITION IMPROVED 330
760 HEPATOCELLULAR INJURY 329
761 FULL BLOOD COUNT ABNORMAL 328
762 HYPERTHYROIDISM 328
763 MADAROSIS 328
764 TACHYPNOEA 328
765 DRY THROAT 327
766 BACTERAEMIA 326
767 DIVERTICULUM 326
768 ILEUS 325
769 NEUROTOXICITY 325
770 UPPER-AIRWAY COUGH SYNDROME 325
771 TARDIVE DYSKINESIA 324
772 INTENTIONAL DRUG MISUSE 323
773 SECRETION DISCHARGE 323
774 ANAL INCONTINENCE 322
775 HYPERCALCAEMIA 322
776 LIGAMENT SPRAIN 322
777 PULMONARY ARTERIAL HYPERTENSION 322
778 MALIGNANT MELANOMA 321
779 MOTOR DYSFUNCTION 321
780 LOWER GASTROINTESTINAL HAEMORRHAGE 320
781 SPINAL OPERATION 320
782 ABSCESS 319
783 CARDIOMYOPATHY 319
784 HAEMODIALYSIS 318
785 NEEDLE ISSUE 317
786 PRODUCT PHYSICAL ISSUE 317
787 QUALITY OF LIFE DECREASED 317
788 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 317
789 DRUG ERUPTION 316
790 INJECTION SITE URTICARIA 315
791 ARTERIOSCLEROSIS 314
792 EXOSTOSIS 314
793 PSYCHOLOGICAL TRAUMA 314
794 VENTRICULAR FIBRILLATION 314
795 BLOOD ALBUMIN DECREASED 313
796 NERVE INJURY 311
797 PHARYNGEAL SWELLING 311
798 INFUSION SITE ERYTHEMA 310
799 INTERNAL HAEMORRHAGE 310
800 HYDRONEPHROSIS 309
801 TOOTH FRACTURE 309
802 PRESCRIBED OVERDOSE 308
803 BLOOD TEST ABNORMAL 307
804 PYELONEPHRITIS 307
805 RED BLOOD CELL SEDIMENTATION RATE INCREASED 307
806 MUSCLE ATROPHY 306
807 GROIN PAIN 305
808 PROSTATIC SPECIFIC ANTIGEN INCREASED 305
809 PSYCHOMOTOR HYPERACTIVITY 305
810 HYPERBILIRUBINAEMIA 304
811 PARALYSIS 304
812 WEIGHT FLUCTUATION 304
813 DERMATITIS ALLERGIC 303
814 RALES 303
815 IMMUNE SYSTEM DISORDER 302
816 SUDDEN DEATH 302
817 JOINT DISLOCATION 301
818 SCHIZOPHRENIA 301
819 HYPERCHOLESTEROLAEMIA 300
820 VENTRICULAR EXTRASYSTOLES 299
821 ACUTE MYELOID LEUKAEMIA 297
822 CYTOMEGALOVIRUS INFECTION 297
823 INTESTINAL PERFORATION 297
824 SPINAL DISORDER 297
825 FLANK PAIN 296
826 GASTRIC HAEMORRHAGE 296
827 GASTROINTESTINAL INFECTION 293
828 JOINT RANGE OF MOTION DECREASED 293
829 DRUG PRESCRIBING ERROR 292
830 MYOPATHY 292
831 SPINAL COMPRESSION FRACTURE 291
832 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 290
833 CARDIOGENIC SHOCK 290
834 LYMPHOPENIA 290
835 BLOOD GLUCOSE ABNORMAL 289
836 MYOSITIS 289
837 FACIAL PARALYSIS 288
838 CYSTIC FIBROSIS 286
839 DYSTONIA 286
840 GASTRIC CANCER 286
841 ANURIA 284
842 PELVIC FRACTURE 284
843 ACUTE CORONARY SYNDROME 283
844 ACUTE HEPATIC FAILURE 283
845 PSEUDOMONAS INFECTION 282
846 HEMIPLEGIA 281
847 INITIAL INSOMNIA 281
848 PELVIC PAIN 281
849 DIARRHOEA HAEMORRHAGIC 280
850 MULTIPLE FRACTURES 280
851 ODYNOPHAGIA 280
852 LARYNGITIS 279
853 RENAL FAILURE CHRONIC 279
854 TOOTH ABSCESS 279
855 DISABILITY 278
856 EAR DISCOMFORT 278
857 MACULAR DEGENERATION 278
858 DUODENAL ULCER 277
859 SALIVARY HYPERSECRETION 277
860 LUNG INFILTRATION 276
861 NEUROLEPTIC MALIGNANT SYNDROME 276
862 MUSCLE STRAIN 274
863 MYELODYSPLASTIC SYNDROME 274
864 ABDOMINAL TENDERNESS 273
865 EYE HAEMORRHAGE 273
866 MULTIPLE ALLERGIES 273
867 COLITIS ISCHAEMIC 272
868 HYPOPNOEA 272
869 PANCREATIC CARCINOMA 272
870 DEVICE LEAKAGE 271
871 ARTERIAL OCCLUSIVE DISEASE 270
872 OCULAR DISCOMFORT 269
873 TRANSFUSION 269
874 ELECTROCARDIOGRAM ABNORMAL 268
875 HYPERTRANSAMINASAEMIA 268
876 INFUSION SITE SWELLING 268
877 TOXIC SKIN ERUPTION 268
878 HEPATITIS CHOLESTATIC 267
879 HYPERTENSIVE CRISIS 267
880 SQUAMOUS CELL CARCINOMA 267
881 TROPONIN INCREASED 267
882 ADRENAL INSUFFICIENCY 265
883 OROPHARYNGEAL DISCOMFORT 265
884 CHOLECYSTITIS CHRONIC 264
885 REBOUND EFFECT 264
886 ABNORMAL FAECES 263
887 BLINDNESS UNILATERAL 263
888 PRODUCT USE COMPLAINT 263
889 ACIDOSIS 262
890 HYPOTHERMIA 262
891 INCORRECT ROUTE OF DRUG ADMINISTRATION 262
892 WOUND INFECTION 262
893 COLON CANCER 260
894 ORAL DISORDER 260
895 DISSEMINATED INTRAVASCULAR COAGULATION 259
896 EXTRAPYRAMIDAL DISORDER 259
897 ATRIOVENTRICULAR BLOCK COMPLETE 258
898 HELICOBACTER INFECTION 258
899 LACERATION 258
900 BRAIN OEDEMA 257
901 OBSTRUCTIVE AIRWAYS DISORDER 256
902 TOOTH EXTRACTION 256
903 BACK INJURY 255
904 DECUBITUS ULCER 255
905 MOUTH SWELLING 255
906 PNEUMONIA BACTERIAL 255
907 PRODUCT DISPENSING ERROR 255
908 LARGE INTESTINE POLYP 254
909 METASTASES TO CENTRAL NERVOUS SYSTEM 253
910 ESCHERICHIA INFECTION 252
911 HUNGER 252
912 ERYTHEMA MULTIFORME 251
913 LYMPHOEDEMA 251
914 MUSCLE DISORDER 251
915 TUBERCULOSIS 251
916 INTESTINAL ISCHAEMIA 250
917 LIPASE INCREASED 250
918 DECREASED ACTIVITY 248
919 OLIGURIA 248
920 ARTERIOSCLEROSIS CORONARY ARTERY 247
921 DROOLING 247
922 IMMUNISATION 247
923 RESPIRATORY RATE INCREASED 247
924 ANKYLOSING SPONDYLITIS 246
925 HYPOALBUMINAEMIA 246
926 NEPHROPATHY TOXIC 245
927 SLUGGISHNESS 245
928 IMMUNOSUPPRESSION 244
929 ORAL MUCOSAL BLISTERING 244
930 PRODUCT TASTE ABNORMAL 244
931 PURPURA 244
932 BOWEL MOVEMENT IRREGULARITY 243
933 SINUS BRADYCARDIA 243
934 ESSENTIAL HYPERTENSION 242
935 ANOREXIA 241
936 GASTRIC POLYPS 241
937 LUPUS-LIKE SYNDROME 241
938 POLYP 241
939 VITREOUS FLOATERS 241
940 BREAST PAIN 240
941 FAECALOMA 240
942 POSTOPERATIVE WOUND INFECTION 240
943 RENAL CANCER 239
944 DECREASED IMMUNE RESPONSIVENESS 238
945 HYPOTONIA 238
946 POOR VENOUS ACCESS 237
947 MOUTH HAEMORRHAGE 236
948 RESPIRATORY SYNCYTIAL VIRUS INFECTION 236
949 FISTULA 235
950 PULMONARY PAIN 233
951 PHARMACEUTICAL PRODUCT COMPLAINT 232
952 SKIN REACTION 232
953 DEVICE OCCLUSION 231
954 POST PROCEDURAL HAEMORRHAGE 231
955 TORSADE DE POINTES 231
956 VITAMIN B12 DEFICIENCY 231
957 APPENDICITIS 230
958 ATRIOVENTRICULAR BLOCK FIRST DEGREE 230
959 BIPOLAR DISORDER 230
960 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 230
961 DRUG DOSE OMISSION BY DEVICE 230
962 FEELING DRUNK 230
963 HICCUPS 230
964 APPLICATION SITE ERYTHEMA 229
965 RIGHT VENTRICULAR FAILURE 229
966 GASTROINTESTINAL INFLAMMATION 228
967 SCAB 228
968 GASTRITIS EROSIVE 226
969 JOINT EFFUSION 226
970 POST PROCEDURAL INFECTION 226
971 LEFT VENTRICULAR DYSFUNCTION 225
972 EXPOSURE VIA SKIN CONTACT 223
973 EYE DISCHARGE 223
974 METASTASES TO LUNG 223
975 MYOCARDITIS 223
976 CONCUSSION 222
977 SCRATCH 222
978 HAND FRACTURE 221
979 NEOPLASM 221
980 MENISCUS INJURY 220
981 ONYCHOCLASIS 220
982 POLYNEUROPATHY 220
983 PRODUCT PRESCRIBING ISSUE 220
984 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 220
985 BRADYKINESIA 219
986 DEVICE BREAKAGE 219
987 MYDRIASIS 219
988 NEPHROTIC SYNDROME 219
989 RED CELL DISTRIBUTION WIDTH INCREASED 219
990 TRICUSPID VALVE INCOMPETENCE 219
991 NAIL DISORDER 218
992 FURUNCLE 217
993 HEPATITIS ACUTE 217
994 PRODUCT ADHESION ISSUE 217
995 CENTRAL NERVOUS SYSTEM LESION 216
996 DIVERTICULUM INTESTINAL 216
997 EYELID OEDEMA 216
998 GOITRE 216
999 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 216